Parsons Capital Management’s GSK GSK Stock Holding History

Parsons Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+4,857	New	+$257K	0.01%	480
2020 Q1	–	Sell	-3,718	Closed	-$218K	–	330
2019 Q4	$218K	Buy	+3,718	New	+$207K	0.02%	328
2017 Q3	–	Sell	-4,674	Closed	-$252K	–	359
2017 Q2	$252K	Hold	4,674	–	–	0.03%	318
2017 Q1	$246K	Buy	4,674 +240	+5%	+$12.2K	0.03%	314
2016 Q4	$213K	Buy	4,434 +92	+2%	+$4.54K	0.03%	316
2016 Q3	$234K	Buy	+4,342	New	+$238K	0.03%	300
2015 Q3	–	Sell	-4,822	Closed	-$251K	–	340
2015 Q2	$251K	Sell	4,822 -40	-0.8%	-$2.25K	0.03%	299
2015 Q1	$280K	Buy	4,862 +544	+13%	+$31.2K	0.04%	272
2014 Q4	$230K	Sell	4,318 -896	-17%	-$50.1K	0.03%	308
2014 Q3	$299K	Sell	5,214 -400	-7%	-$24.5K	0.04%	278
2014 Q2	$376K	Buy	5,614 +160	+3%	+$10.8K	0.05%	255
2014 Q1	$364K	Sell	5,454 -40	-0.7%	-$2.7K	0.05%	259
2013 Q4	$367K	Hold	5,494	–	–	0.06%	252
2013 Q3	$345K	Buy	5,494 +216	+4%	+$13.9K	0.06%	242
2013 Q2	$329K	Buy	+5,278	New	+$335K	0.06%	238

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Parsons Capital Management's GSK Position: Q2 2026 in Review

Parsons Capital Management opened a new position in GSK (GSK) in Q2 2026: 4,857 shares worth $255K. The stake represents 0.01% of the portfolio and ranks #480 among its holdings. This is a return to the name: Parsons Capital Management previously reported a position in GSK as recently as Q4 2019.

Parsons Capital Management first reported a position in GSK in Q2 2013 and has held it in 15 quarters since. The position peaked at $376K in Q2 2014. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Parsons Capital Management held 4,857 shares of GSK worth $255K as of Q2 2026.
GSK was a new Parsons Capital Management position in Q2 2026.
GSK made up 0.01% of Parsons Capital Management's portfolio in Q2 2026, its #480 holding.
Parsons Capital Management first reported a position in GSK in Q2 2013 and has held it in 15 quarters since.
Parsons Capital Management's GSK position peaked at $376K in Q2 2014.
1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.